{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:03:22Z","timestamp":1791230602597,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23bk0104126"],"award-info":[{"award-number":["JP23bk0104126"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.stem.2025.07.012","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:50:44Z","timestamp":1755622244000},"page":"1346-1355.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson\u2019s disease"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7411-1828","authenticated-orcid":false,"given":"Asuka","family":"Morizane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takero","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Anazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukatsu","family":"Sawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodaka","family":"Yamakado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Taruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumu K.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2025.07.012_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stem.2025.07.012_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2967\/jnumed.109.066811","article-title":"Dopamine cell implantation in Parkinson\u2019s disease: long-term clinical and (18)F-FDOPA PET outcomes","volume":"51","author":"Ma","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","article-title":"Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease: Two Case Reports","volume":"71","author":"Kefalopoulou","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.stem.2025.07.012_bib7","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2025.07.012_bib8","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson\u2019s Disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Non-human Primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2025.07.012_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.stem.2025.07.012_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2025.07.012_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-019-0106-0","article-title":"Overview: an iPS cell stock at CiRA","volume":"39","author":"Umekage","year":"2019","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.stem.2025.07.012_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.stem.2025.07.012_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medj.2022.10.003","article-title":"A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population","volume":"4","author":"Yoshida","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.stem.2025.07.012_bib15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib16","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3390\/jcm9072217","article-title":"HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration","volume":"9","author":"Sugita","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40472-016-0115-8","article-title":"What Is Direct Allorecognition?","volume":"3","author":"Boardman","year":"2016","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.stem.2025.07.012_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson\u2019s disease","volume":"25","author":"Barker","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.stem.2024.12.005","article-title":"Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update","volume":"32","author":"Kirkeby","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2025.07.012_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.stem.2025.07.012_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.stem.2025.07.012_bib22","first-page":"1946","article-title":"Pharmacokinetic animal PET study of FK506 as a potent neuroprotective agent","volume":"45","author":"Murakami","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib23","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1471-4159.1990.tb03128.x","article-title":"Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A","volume":"55","author":"Begley","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.stem.2025.07.012_bib24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00259-018-3974-7","article-title":"TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis","volume":"45","author":"Unterrainer","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.stem.2025.07.012_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-017-0340-x","article-title":"TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis","volume":"7","author":"Vomacka","year":"2017","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.stem.2025.07.012_bib26","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3233\/JAD-230631","article-title":"Microglial Imaging in Alzheimer\u2019s Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study","volume":"96","author":"Yang","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.stem.2025.07.012_bib27","doi-asserted-by":"crossref","first-page":"10441","DOI":"10.1073\/pnas.1902566116","article-title":"Generation of hypoimmunogenic human pluripotent stem cells","volume":"116","author":"Han","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2025.07.012_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2025.07.012_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101162","article-title":"Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells","volume":"23","author":"Zhao","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.stem.2025.07.012_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.stem.2024.02.001","article-title":"Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate","volume":"31","author":"Hu","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2025.07.012_bib31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stemcr.2020.02.006","article-title":"Generation of Retinal Pigment Epithelial Cells Derived from Human Embryonic Stem Cells Lacking Human Leukocyte Antigen Class I and II","volume":"14","author":"Petrus-Reurer","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2025.07.012_bib32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","article-title":"Engineering universal cells that evade immune detection","volume":"19","author":"Lanza","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stem.2025.07.012_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.stemcr.2017.07.020","article-title":"NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs","volume":"9","author":"Ichise","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2025.07.012_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2025.07.012_bib35","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s00259-016-3444-z","article-title":"Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain","volume":"43","author":"Feeney","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.stem.2025.07.012_bib36","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2967\/jnumed.115.169078","article-title":"Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein","volume":"57","author":"Fan","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.stem.2025.07.012_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059243","article-title":"Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions","volume":"8","author":"Yanagimachi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.stem.2025.07.012_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/gt.2012.59","article-title":"TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells","volume":"20","author":"Haruta","year":"2013","journal-title":"Gene Ther."}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590925002693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590925002693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:22:36Z","timestamp":1778833356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590925002693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1934590925002693"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2025.07.012","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2025.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}